Inventor
MANGELSDORF DAVID J
US19 patents
⚠️ This page may combine multiple inventors who share the name “MANGELSDORF DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SALK INST FOR BIOLOGICAL STUDI
10 patentsUS5710004AJan 20, 1998
Methods of using novel steroid hormone orphan receptors
SALK INST FOR BIOLOGICAL STUDI99 citations97
US5723329AMar 3, 1998
DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells
SALK INST FOR BIOLOGICAL STUDI77 citations96
US5571696ANov 5, 1996
Receptors
SALK INST FOR BIOLOGICAL STUDI57 citations95
US6506917B1Jan 14, 2003
Compounds and compositions useful for modulation of processes mediated by RXR
SALK INST FOR BIOLOGICAL STUDI18 citations92
US5968989AOct 19, 1999
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI17 citations92
US5696233ADec 9, 1997
Orphan steroid hormone receptors
SALK INST FOR BIOLOGICAL STUDI24 citations92
US5990163ANov 23, 1999
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI51 citations90
US5932622AAug 3, 1999
Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
SALK INST FOR BIOLOGICAL STUDI14 citations73
US7501487B1Mar 10, 2009
Retinoid receptor compositions and methods
SALK INST FOR BIOLOGICAL STUDI5 citations63
US6576676B1Jun 10, 2003
Means for the modulation of processes mediated by retinold receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI4 citations62
UNIV TEXAS
5 patentsUS8007994B2Aug 30, 2011
Compositions and methods of modulating cholesterol metabolism
UNIV TEXAS9 citations76
US7825269B2Nov 2, 2010
Ligands for nematode nuclear receptors and uses thereof
UNIV TEXAS7 citations66
US6835866B1Dec 28, 2004
Compositions and methods of modulating cholesterol metabolism
UNIV TEXAS12 citations65
US12178848B2Dec 31, 2024
Methods and compositions for the treatment of exocrine pancreatic insufficiency
UNIV TEXAS0 citations54
US11318186B2May 3, 2022
Use of FGF21 in methods of increasing exocrine pancreatic secretion
UNIV TEXAS0 citations54